High serum YKL-40 level positively correlates with coronary artery disease

被引:2
作者
Jin, Yan [1 ]
Cao, Jia-Ning [1 ]
Wang, Chun-Xia [1 ]
Feng, Qiu-Ting [1 ]
Ye, Xin-He [1 ]
Xu, Xin [1 ]
Yang, Cheng-Jian [1 ]
机构
[1] Nanjing Med Univ, WuXi Hosp 2, Dept Cardiol, 68 Zhongshan Rd, Wuxi 214002, Peoples R China
关键词
CAD; coronary artery disease; diagnosis; Gensini score; predictive value; ROC curve; sensitivity; serum; specificity; YKL-40; HEART-DISEASE; INFLAMMATORY BIOMARKER; PROMOTER REGION; PLASMA YKL-40; ATHEROSCLEROSIS; CHI3L1; MARKER; GENE; EXPRESSION; PREDICTION;
D O I
10.2217/bmm-2016-024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: We investigated the predictive value of chitinase-like protein YKL-40 in coronary artery disease (CAD). Patients: Serum YKL-40 levels in 116 CAD patients and 82 healthy controls were analyzed. Severity of CAD was evaluated using Gensini scores. Spearman's correlation was used to evaluate the correlation between Gensini scores and YKL-40 levels. The predictive value of YKL-40 was determined by receivers operating characteristic curve analysis. Results: Serum YKL-40 levels were significantly elevated in CAD group as compared with control group. A positive correlation was found between the serum YKL-40 level and Gensini score. The optimum cut-off value of YKL-40 concentration was 127.7 ng/ ml for distinguishing CAD patients from healthy controls with a 75.9% sensitivity and 57.3% specificity. Conclusion: A positive correlation exists between YKL-40 levels and CAD, and YKL-40 might be a useful adjunct in the diagnosis of CAD.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [21] Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus
    Kim, Hyun Min
    Lee, Byung-Wan
    Song, Young-Mi
    Kim, Won Jin
    Chang, Hyuk-Jae
    Choi, Dong-Hoon
    Yu, Hee Tae
    Kang, EunSeok
    Cha, Bong Soo
    Lee, Hyun Chul
    CARDIOVASCULAR DIABETOLOGY, 2012, 11
  • [22] Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke
    Chen, X. -L.
    Li, Q.
    Huang, W. -S.
    Lin, Y. -S.
    Xue, J.
    Wang, B.
    Jin, K. -L.
    Shao, B.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (02): : 97 - 102
  • [23] Circulating lncRNA ANRIL level positively correlates with disease risk, severity, inflammation level and poor prognosis of coronary artery disease
    Qin, Zheng
    Liu, Danan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 8964 - 8970
  • [24] Fasting Serum Level of Fatty-Acid-Binding Protein 4 Positively Correlates With Metabolic Syndrome in Patients With Coronary Artery Disease
    Hsu, Bang-Gee
    Chen, Yu-Chih
    Lee, Ru-Ping
    Lee, Chia-Chi
    Lee, Chung-Jen
    Wang, Ji-Hung
    CIRCULATION JOURNAL, 2010, 74 (02) : 327 - 331
  • [25] Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study
    Kose, Murat
    Emet, Samim
    Akpinar, Timur Selcuk
    Kocaaga, Mehmet
    Cakmak, Ramazan
    Akarsu, Murat
    Yuruyen, Gulden
    Arman, Yucel
    Tukek, Tufan
    ANGIOLOGY, 2015, 66 (08) : 727 - 731
  • [26] YKL-40 Protein Correlates with the Phenotype of Asthma
    Specjalski, Krzysztof
    Chelminska, Marta
    Jassem, Ewa
    LUNG, 2015, 193 (02) : 189 - 194
  • [27] Plasma YKL-40 levels correlate with the severity of coronary atherosclerosis assessed with the SYNTAX score
    Sciborski, Krzysztof
    Kuliczkowski, Wiktor
    Karolko, Bozena
    Bednarczyk, Dawid
    Protasiewicz, Marcin
    Mysiak, Andrzej
    Negrusz-Kawecka, Marta
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (11): : 644 - 648
  • [28] Association between serum YKL-40 level and dysglycemia in cystic fibrosis
    Bouvet, Guillaume F.
    Maignan, Maxime
    Arslanian, Elizabeth
    Coriati, Adele
    Rabasa-Lhoret, Remi
    Berthiaume, Yves
    CYTOKINE, 2015, 71 (02) : 296 - 301
  • [29] Prognostic effect of serum and tissue YKL-40 levels in bladder cancer
    Tschirdewahn, Stephan
    Reis, Henning
    Niedworok, Christian
    Nyirady, Peter
    Szendroei, Attila
    Schmid, Kurt W.
    Shariat, Shahrokh F.
    Kramer, Gero
    vom Dorp, Frank
    Ruebben, Herbert
    Szarvas, Tibor
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (05) : 663 - 669
  • [30] Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
    Iwamoto, Fabio M.
    Hottinger, Andreas F.
    Karimi, Sasan
    Riedel, Elyn
    Dantis, Jocelynn
    Jahdi, Maryam
    Panageas, Katherine S.
    Lassman, Andrew B.
    Abrey, Lauren E.
    Fleisher, Martin
    DeAngelis, Lisa M.
    Holland, Eric C.
    Hormigo, Adilia
    NEURO-ONCOLOGY, 2011, 13 (11) : 1244 - 1251